3658 results for «247»
3658 results
Coronary Pot Pourri 1
10 Dec 2025 – From GulfPCR-GIM 2025
This session presents a diverse array of challenging coronary cases, highlighting complex diagnostic and therapeutic dilemmas. It offers practical insights into decision-making for scenarios such as difficult catheterizations, myocardial bridging, and unexpected procedural challenges.
The most impactful trials of 2025
10 Dec 2025 – From GulfPCR-GIM 2025
Review the most impactful cardiovascular intervention trials anticipated in 2025, analyzing their methodology and clinical applicability. This session facilitates understanding how emerging evidence can be integrated into daily interventional cardiology practice.
Challenging TAVI cases - Part 1
10 Dec 2025 – From GulfPCR-GIM 2025
Addressing complex TAVI cases, this session focuses on procedural challenges and advanced strategies to optimize safety and outcomes. Topics include high-risk valvuloplasty, management with prosthetic valves, and considerations in patients with valve thrombus.
Complex CTO interventions - Part 1
10 Dec 2025 – From GulfPCR-GIM 2025
Explore advanced techniques in complex chronic total occlusion (CTO) interventions, featuring IVUS-guided retrograde wire facilitated antegrade approaches, novel multiwire plaque modification for uncrossable in-stent restenosis CTOs, and strategic navigation through challenging scenarios. This session highlights key procedural insights and complication management strategies essential for success in...
GulfPCR-GIM 2025 Opening Ceremony
10 Dec 2025 – From GulfPCR-GIM 2025
The GulfPCR-GIM 2025 Opening Ceremony marks the commencement of this prestigious cardiology congress, setting the tone for a comprehensive program dedicated to advancing interventional cardiology practice and research in the Gulf region and beyond.
GulfPCR-GIM 2025 Closing Ceremony
11 Dec 2025 – From GulfPCR-GIM 2025
The GulfPCR-GIM 2025 Closing Ceremony marks the conclusion of an insightful and comprehensive congress, highlighting the latest advances and discussions in interventional cardiology. This session encapsulates the key takeaways and emerging themes that will shape future clinical practice and research in cardiology.
Seeing is believing: OCT-guided calcium modification in complex PCI
10 Dec 2025 – From GulfPCR-GIM 2025
Explore the management of heavily calcified LAD lesions in this PCRGulf-GIM 2025 session. Discover how OCT imaging guides lesion assessment, differentiates superficial from deep calcium, and informs the need for plaque modification. Learn when and how to use orbital atherectomy or intravascular lithotripsy, and follow the...
Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?
10 Dec 2025 – From GulfPCR-GIM 2025
This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.
The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...
Cracking calcium in modern PCI
10 Dec 2025 – From GulfPCR-GIM 2025
Calcified coronary lesions are a major challenge in PCI. This PCRGulf-GIM 2025 session showcases a complex case with intravascular imaging, highlighting how IVUS 123 guides each step.
From planning the procedure and understanding calcium distribution, to lesion preparation with modern modification tools, and post-PCI assessment to confirm...
PCR Valves e-Course: Sponsored Programme
EuroIntervention: Meet Cory, your new AI Assistant!
26 Mar 2024
Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.
All-new EuroPCR 2021: what’s on?
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...
Author
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...
Author
Author
